Navigation Links
Cytopia Commences Second Phase II Study in Brain Cancer
Date:9/4/2008

ion-free survival at six

months using the dose of CYT997 identified in the

Phase Ib component (Ph II).

Secondary endpoints Objective response rate, overall survival, safety

and tolerability, effects on pharmacodynamic

markers of vascular disruption and tumor apoptosis,

and pharmacokinetic analyses.

Blinding status Not blinded.

Product development Drug substance and drug product are manufactured to

status GMP standards.

Treatment method

Route 24 hour intravenous infusion dose (CYT997).

Frequency Day 2 of a 21 day cycle.

Dose-levels Maximum dose of 200 mg/m2 CYT997 dihydrochloride.

Number of trial

subjects Estimated 35 patients.

Subject selection Eligible patients must have glioblastoma multiforme

criteria that has progressed after surgery, radiation

therapy and temozolomide chemotherapy.

Trial location Initial site in Melbourne, Australia.

Expected completion 2Q 2010

Trial standard ICH-GCP

This trial follows the successful conclusion last year of the company's Phase I safety study for intravenous CYT997, in which a prolonged delay in tumor growth was observed in seven of the study's 31 advanced cancer patients.

Significant perturbations in tumor blood flow were also demonstrated, suggesting that CYT997 potently disrupts tumor blood vessels. Findings from this study were recently presented at the American Society of Clinical Oncology Annual Meeting which attracts some 30,000 cancer specialists from around the globe.

Cytopia is also investigating the safety and anti-vascular activity of CYT997 when administered by mouth. Preliminary data from the company's Phase I oral s
'/>"/>

SOURCE Cytopia Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
2. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
3. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
4. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
5. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
6. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
7. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
8. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
9. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
10. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
11. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will report ... Ken Berger , CEO, and Ed Borkowski , ... live via telephone. To participate in the conference call ... To participate in the conference call outside the U.S. and ... conference ID is 72195398. Participants should dial in 10 minutes ...
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
(Date:5/17/2013)... SEATTLE , May 17, 2013  Atossa Genetics, Inc. ... today that Kyle Guse , Chief Financial ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hyatt Hotel. The Company,s presentation is scheduled ... via a live webcast. To access the webcast, go to ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3
(Date:5/19/2013)... Colorado (PRWEB) May 19, 2013 Farming ... first seed in the ground 10,000 years ago. Most ... increased farm productivity by using genetically engineered seeds and ... now seeing a backlash to these techniques due to ... and chemicals and a corresponding surge in interest in ...
(Date:5/19/2013)... Vegas, Nevada (PRWEB) May 19, 2013 ... agency , is proud to announce the launch it's ... Awards at the MGM Grand on 5/19/2013. Consumers traveling ... all new special pricing available on VegasHotelEscapes.com's website. Travelers ... that they beat any competitors price. , Vegas Hotel ...
(Date:5/19/2013)... Exciting new Skin Brushes are available ... great practice known through the ages but is a ... body brushing, has so many benefits for our health ... "We love that circulation and lymphatic systems get a ... skin, is supported through Skin Brushing." , Why is ...
(Date:5/19/2013)... Aires, Argentina: Yoga classes ( clases de Yoga ) ... the Sivananda Yoga Vedanta Center. The center is ... Classes are 90 minutes and are offered all week ... calm environment, allowing visitors to enjoy the benefits of ... others. , The Yoga classes follow the following principles: ...
(Date:5/19/2013)... Minor fender benders and serious car ... parties to the accident to respond appropriately to the ... Prevention (CDC) data from 2010, accidents, including car accidents, ... In fact, in 2005, automobile accident-related deaths ... than 2.3 million drivers and passengers receive treatment in ...
Breaking Medicine News(10 mins):Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2
... LOS ANGELES (May 30, 2012) Patricia Dickson, M.D., ... at Harbor-UCLA Medical Center (LA BioMed), is co-principal investigator ... million grant from the California Institute for Regenerative Medicine ... develop a stem cell based therapy for the treatment ...
... HealthDay Reporter , TUESDAY, May 29 (HealthDay News) -- ... twice as likely to have a child with autism spectrum ... Exactly how, or even if, fevers may increase the risk ... women should not panic if they do develop a fever ...
... premier event for sleep and circadian science that blends the ... SLEEP 2012, the 26th Annual Meeting of the Associated Professional ... B. Hynes Veterans Memorial Convention Center. SLEEP is filled with ... medicine and sleep research. This year,s program (available at ...
... (HealthDay News) -- ,Adult survivors of childhood cancer can ... of the long-term physical effects of their cancer treatment, ... the Childhood Cancer Survivor Study to assess the effects ... more than 14,000 adult survivors of childhood cancer. The ...
... the Dana-Farber/Children,s Hospital Cancer Center have developed an ... chemotherapy and radiation often encountered in certain blood ... The strategy could pave the way ... and refractory blood cancers, which are difficult to ...
... AURORA, Colo. (May 29, 2012) A Colorado ... designed to illuminate financial links between doctors and pharmaceutical ... physicians prescribe. "If the policymakers who passed these ... be disappointed," said the study,s lead author, Genevieve Pham-Kanter, ...
Cached Medicine News:Health News:LA BioMed's Dr. Patricia Dickson researching treatments for neurodegenerative disorders 2Health News:Fever During Pregnancy May Raise Odds for Autism in Offspring 2Health News:Fever During Pregnancy May Raise Odds for Autism in Offspring 3Health News:SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston 2Health News:Emotional Woes May Last for Childhood Cancer Survivors 2Health News:New drug strategy attacks resistant leukemia and lymphoma 2Health News:New drug strategy attacks resistant leukemia and lymphoma 3Health News:New federal disclosure law may have little impact on drugs prescribed 2
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: